People vaccinated against COVID-19 may be sick…See more ​‍͏

 

COVID-19 vaccines in 2026 remain highly effective at reducing severe illness, hospitalization, and death, especially with updated Omicron-adapted boosters. While vaccinated individuals can still experience breakthrough infections, the overall risk of serious outcomes is significantly lower compared to the unvaccinated…@@@

Voir plus

blog

Dvd

Choisir Son Forfait

GetHealth Updates

How COVID-19 Vaccines Work

• Immune response:  Vaccines train the immune system to recognize SARS-CoV-2 and mount a rapid defense.
• Platforms: mRNA (Pfizer, Moderna), protein-based (Novavax), and adenovirus-vectored  vaccines remain widely used.
• Boosters: Updated formulations target newer variants like JN.1, improving protection against circulating strains.

Effectiveness in 2025–2026

• Hospitalization Protection: Updated  vaccines reduced hospitalizations by ~55% among adults with COVID-like illness.
• Emergency Care Visits: Effectiveness against ED/urgent care visits was ~50%, showing strong real-world impact.
• Variant Adaptation: Omicron-adapted boosters provide superior protection compared to older monovalent doses.

Safety Profile

• Adverse Events: Serious side effects remain rare, with most reactions mild (fever, fatigue, injection-site pain).
• Long-term Data: Evidence shows sustained safety, though more research is needed for children,  cancer patients, and immunocompromised groups.

WHO Guidance (2026)

• Routine Vaccination: Recommended for high-risk groups (elderly, immunocompromised, healthcare workers).
• Coadministration:  COVID-19 vaccines can be safely given alongside influenza and other routine immunizations.
• Future Research: Focus on durability of protection, variant-specific boosters, and equity in global distribution.

Risks and Trade-offs

• Breakthrough  Infections: Vaccinated individuals may still contract  COVID-19, especially with immune-evading variants.
• Waning Immunity: Protection decreases over time, making boosters essential.
• Global Inequity: Access to updated vaccines remains uneven, leaving vulnerable populations at risk.
  

  Conclusion

  COVID-19 vaccination continues to be one of the most effective  public health tools. While not perfect,  vaccines drastically reduce severe outcomes and remain safe across populations. The future lies in variant-adapted boosters, global equity, and ongoing research to refine strategies.